Julia Strandberg, Chief Commercial Officer at Pear Therapeutics, Inc. (PEAR), sold 12,688 shares at $1.13 ($14K) on 2023-01-20, disclosed to the SEC on 2023-01-24.
Open-market sale of $14k PEAR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.